Upadacitinib with or without topical corticosteroids improves health-related quality of life in adolescent and adult patients with moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)

被引：0

作者：

Prajapati, Vimal H. ^{[1
,2
,3
,4
,5
,6
,7
]}

Rosmarin, David ^{[8
]}

Shumack, Stephen ^{[9
,10
,11
]}

Calimlim, Brian M. ^{[12
]}

Takemoto, Shunya ^{[10
]}

Hu, Xiaofei ^{[12
]}

Ladizinski, Barry ^{[12
]}

Warren, Richard B. ^{[13
]}

机构：

[1] Univ Calgary, Div Dermatol, Calgary, AB, Canada

[2] Univ Calgary, Dept Pediat, Sect Community Pediat, Calgary, AB, Canada

[3] Univ Calgary, Dept Pediat, Sect Pediat Rheumatol, Calgary, AB, Canada

[4] Univ Calgary, Dept Med, Calgary, AB, Canada

[5] Skin Hlth & Wellness Ctr, Calgary, AB, Canada

[6] Dermatol Res Inst, Calgary, AB, Canada

[7] Prob Med Res, Calgary, AB, Canada

[8] Tufts Med Ctr, Dept Dermatol, Boston, MA 02111 USA

[9] Univ Sydney, Sydney Med Sch Northern, Sydney, NSW, Australia

[10] Skin Hosp, Darlinghurst, NSW, Australia

[11] Royal North Shore Hosp Sydney, Sydney, NSW, Australia

[12] AbbVie Inc, N Chicago, IL USA

[13] Univ Manchester, Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester NIHR Biomed Res Ctr, Manchester, Lancs, England

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

174

引用

页码：E81 / E81

页数：1